Breast cancer screening utilization and understanding of current guidelines among rural U.S. women with private insurance

Breast Cancer Research and Treatment

Volumn 153, Issue 3, 2015, Pages 659-667

  Peppercorn, Jeffrey ^a   Houck, Kevin ^b   Beri, Nina ^b   Villagra, Victor ^c   Wogu, Adane F ^d   Lyman, Gary H ^e   Wheeler, Stephanie B ^d  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^d University of North Carolina at Chapel Hill   (United States)

^e USA   (United States)

Author keywords

Breast cancer screening; Guidelines; Health disparities; Rural; Survey

Indexed keywords

ADULT; ARTICLE; ATTITUDE TO HEALTH; AWARENESS; BREAST CANCER; CANCER SCREENING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HEALTH CARE DISPARITY; HEALTH CARE UTILIZATION; HEALTH SURVEY; HUMAN; INSURANCE; MAMMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RURAL AREA; UNITED STATES; WOMEN'S HEALTH; AGED; BREAST NEOPLASMS; CULTURAL ANTHROPOLOGY; EARLY CANCER DIAGNOSIS; HEALTH INSURANCE; MASS SCREENING; MIDDLE AGED; PATIENT ATTITUDE; PERCEPTION; RURAL POPULATION; SOCIOECONOMICS;

ADULT; AGED; BREAST NEOPLASMS; CROSS-SECTIONAL STUDIES; CULTURE; EARLY DETECTION OF CANCER; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HUMANS; INSURANCE, HEALTH; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PERCEPTION; PRACTICE GUIDELINES AS TOPIC; RURAL POPULATION; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84942984857     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-015-3566-1     Document Type: Article

References (30)

1. Beverage JN, Sissung TM, Sion AM, Danesi R, Figg WD (2007) CYP2D6 polymorphisms and the impact on tamoxifen therapy. J Pharm Sci 96(9):2224–2231
2. Donahue SR, Flockhart DA, Abernethy DR, Ko JW (1997) Ticlopidine inhibition of phenytoin metabolism mediated by potent inhibition of CYP2C19. Clin Pharmacol Ther 62(5):572–577
3. Dowsett M, Goldhirsch A, Hayes DF, Senn HJ, Wood W, Viale G (2007) International Web-based consultation on priorities for translational breast cancer research. Breast Cancer Res 9(6):R81
4. Broeders M, Moss S, Nystrom L, Njor S, Jonsson H, Paap E, Massat N, Duffy S, Lynge E, Paci E et al (2012) The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies. J Med Screen 19(Suppl 1):14–25
5. Tabar L, Vitak B, Chen TH, Yen AM, Cohen A, Tot T, Chiu SY, Chen SL, Fann JC, Rosell J et al (2011) Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology 260(3):658–663
6. Coldman A, Phillips N, Wilson C, Decker K, Chiarelli AM, Brisson J, Zhang B, Payne J, Doyle G, Ahmad R (2014) Pan-Canadian study of mammography screening and mortality from breast cancer. J Natl Cancer Inst 106(11)
7. Tabar L, Vitak B, Chen HH, Yen MF, Duffy SW, Smith RA (2001) Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer 91(9):1724–1731
8. Duffy SW, Tabar L, Chen HH, Holmqvist M, Yen MF, Abdsalah S, Epstein B, Frodis E, Ljungberg E, Hedborg-Melander C et al (2002) The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer 95(3):458–469
9. Otto SJ, Fracheboud J, Looman CW, Broeders MJ, Boer R, Hendriks JH, Verbeek AL, de Koning HJ, National Evaluation Team for Breast Cancer S (2003) Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet 361(9367):1411–1417
10. Barth RJ Jr, Gibson GR, Carney PA, Mott LA, Becher RD, Poplack SP (2005) Detection of breast cancer on screening mammography allows patients to be treated with less-toxic therapy. AJR Am J Roentgenol 184(1):324–329
11. Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA (2014) Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ 348:g366
12. Lauby-Secretan B, Scoccianti C, Loomis D, Benbrahim-Tallaa L, Bouvard V, Bianchini F, Straif K, International Agency for Research on Cancer Handbook Working G (2015) Breast-cancer screening–viewpoint of the IARC Working Group. N Engl J Med 372(24):2353–2358
13. EBCTCG (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365(9472):1687–1717
14. Eisinger F (2008) CYP2D6 and Ockham’s razor. J Clin Oncol 26(4):686–687 (author reply 687)
15. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L (2009) Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med 151(10):727–737
16. Partridge AH, Winer EP (2009) On mammography–more agreement than disagreement. N Engl J Med 361(26):2499–2501
17. Kopans DB (2015) An open letter to panels that are deciding guidelines for breast cancer screening. Breast Cancer Res Treat 151(1):19–25
18. Purc-Stephenson RJ, Gorey KM (2008) Lower adherence to screening mammography guidelines among ethnic minority women in America: a meta-analytic review. Prev Med 46(6):479–488
19. Onitilo AA, Engel JM, Liang H, Stankowski RV, Miskowiak DA, Broton M (2013) Doi SA Mammography utilization: patient characteristics and breast cancer stage at diagnosis. AJR Am J Roentgenol 201(5):1057–1063
20. Paskett ED, Tatum C, Rushing J, Michielutte R, Bell R, Foley KL, Bittoni M, Dickinson S (2004) Racial differences in knowledge, attitudes, and cancer screening practices among a triracial rural population. Cancer 101(11):2650–2659
21. Nguyen-Pham S, Leung J, McLaughlin D (2014) Disparities in breast cancer stage at diagnosis in urban and rural adult women: a systematic review and meta-analysis. Ann Epidemiol 24(3):228–235
22. Singh GK, Williams SD, Siahpush M, Mulhollen A (2011) Socioeconomic, rural-urban, and racial inequalities in US cancer mortality: part I-all cancers and lung cancer and part ii-colorectal, prostate, breast, and cervical cancers. J Cancer Epidemiol 2011:107497
23. Meissner HI, Klabunde CN, Breen N, Zapka JM (2012) Breast and colorectal cancer screening: U.S. primary care physicians’ reports of barriers. Am J Prev Med 43(6):584–589
24. Sprague BL, Bolton KC, Mace JL, Herschorn SD, James TA, Vacek PM, Weaver DL, Geller BM (2014) Registry-based study of trends in breast cancer screening mammography before and after the 2009 U.S. Preventive Services Task Force recommendations. Radiology 270(2):354–361
25. Pace LE, He Y, Keating NL (2013) Trends in mammography screening rates after publication of the 2009 US Preventive Services Task Force recommendations. Cancer 119(14):2518–2523
26. U.S. Department of Agriculture Cooperative Soil Survey Regions [http://www.nrcs.usda.gov/wps/portal/nrcs/detail/soils/survey/partnership/ncss/?cid=nrcs142p2_053475]
27. Wheeler SB, Kuo TM, Durham D, Frizzelle B, Reeder-Hayes K, Meyer AM (2014) Effects of distance to care and rural or urban residence on receipt of radiation therapy among North Carolina Medicare enrollees with breast cancer. N C Med J 75(4):239–246
28. Feldstein AC, Perrin N, Rosales AG, Schneider J, Rix MM, Keels K, Schoap S, Glasgow RE (2009) Effect of a multimodal reminder program on repeat mammogram screening. Am J Prev Med 37(2):94–101
29. Hegenscheid K, Hoffmann W, Fochler S, Domin M, Weiss S, Hartmann B, Bick U, Hosten N (2011) Telephone counseling and attendance in a national mammography-screening program a randomized controlled trial. Am J Prev Med 41(4):421–427
30. Kelaher M, Cawson J, Miller J, Kavanagh A, Dunt D, Studdert DM (2008) Use of breast cancer screening and treatment services by Australian women aged 25–44 years following Kylie Minogue’s breast cancer diagnosis. Int J Epidemiol 37(6):1326–1332